Completed PHASE1 INTERVENTIONAL 1-arm NCT04143750

The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

The Mass Balance and Biotransformation Study of [14C] Vicagrel in Chinese Healthy Adult Male Volunteers

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Updated 5 times since 2019 Last updated: Apr 1, 2020 Started: Nov 11, 2019 Primary completion: Dec 29, 2019 Completion: Jan 14, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Male Adult and is currently completed. Jiangsu vcare pharmaceutical technology co., LTD leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
May 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Not Yet Recruiting → Completed
Nov 2019 — May 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu vcare pharmaceutical technology co., LTD

Data source: Jiangsu vcare pharmaceutical technology co., LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suzhou, China